Julie Tsai

1.4k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Julie Tsai is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Julie Tsai has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Julie Tsai's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Genomics and Diagnostics (5 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Julie Tsai is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Genomics and Diagnostics (5 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Julie Tsai collaborates with scholars based in Canada, United States and Spain. Julie Tsai's co-authors include Lin Wu, Khosrow Adeli, Wei Qiu, Wen Wei, Boe Sandahl Sørensen, Peter Meldgaard, Ebba Nexø, Britta Weber, Qiaozhu Su and Tony Mok and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Julie Tsai

17 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

2015 367 citations Tony Mok, Yi‐Long Wu et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Julie Tsai

Since Specialization

Citations

This map shows the geographic impact of Julie Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Tsai more than expected).

Fields of papers citing papers by Julie Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Tsai. The network helps show where Julie Tsai may publish in the future.

Co-authorship network of co-authors of Julie Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Tsai. A scholar is included among the top collaborators of Julie Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Tsai. Julie Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy breakdown → 2015 ·Clinical Cancer Research ·Tony Mok, Yi‐Long Wu, Jin Soo Lee, Chong‐Jen Yu, Virote Sriuranpong, Jennifer Sandoval-Tan, Guia Ladrera, Sumitra Thongprasert, Vichien Srimuninnimit, Meilin Liao, Yunzhong Zhu, Caicun Zhou, Fatima Fuerte, Benjamin Margono, Wei Wen, Julie Tsai, Matt Truman, Barbara Klughammer, David S. Shames, Lin Wu	367
2	Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays 2014 ·BMC Cancer ·Britta Weber, Peter Meldgaard, Henrik Hager, Lin Wu, Wen Wei, Julie Tsai, Azza A. Khalil, Ebba Nexø, Boe Sandahl Sørensen	127
3	Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor‐sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung cancer during treatment with erlotinib 2014 ·Cancer ·Boe Sandahl Sørensen, Lin Wu, Wen Wei, Julie Tsai, Britta Weber, Ebba Nexø, Peter Meldgaard	157
4	Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer 2013 ·Journal of Clinical Pathology ·Fernando López‐Ríos, Bárbara Angulo, (unknown), (unknown), Rebeca Martínez, Esther Conde, Felice Shieh, Julie Tsai, (unknown), (unknown), H. Jeffrey Lawrence, David González de Castro	43
5	Analytic performance studies and clinical reproducibility of a real-time PCRassay for the detection of epidermal growth factor receptor gene mutations informalin-fixed paraffin-embedded tissue specimens of non-small cell lungcancer 2013 ·BMC Cancer ·Patrick O’Donnell, (unknown), (unknown), (unknown), (unknown), Julie Tsai, Mari Christensen, (unknown), (unknown), Felice Shieh, Wen Wei, H. Jeffrey Lawrence, Lin Wu, (unknown), K. Bloom, Warren Maltzman, Steven M. Anderson, Stephen Soviero	34
6	Detection of EGFR-activating mutations from plasma DNA as a potent predictor of survival outcomes in FASTACT 2: A randomized phase III study on intercalated combination of erlotinib (E) and chemotherapy (C). 2013 ·Journal of Clinical Oncology ·Tony Mok, Yi‐Long Wu, Jin Soo Lee, Chong‐Jen Yu, Virote Sriuranpong, Wei Wen, Julie Tsai, Matt Truman, Barbara Klughammer, Lin Wu	9
7	Abstract 1707: A real-time PCR assay for detecting EGFR mutations in formalin-fixed paraffin-embedded tissue (FFPET) specimens of non-small cell lung cancer (NSCLC) 2012 ·Cancer Research ·Patrick O’Donnell, (unknown), (unknown), (unknown), (unknown), Julie Tsai, Mari Christensen, (unknown), Shih‐Chang Chien, (unknown), H. Jeffrey Lawrence, Stephen Soviero	2
8	Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance # 2009 ·Hepatology ·Qiaozhu Su, Julie Tsai, Elaine Xu, Wei Qiu, Erika Bereczki, Miklós Sántha, Khosrow Adeli	88
9	Inflammatory NF-κB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production 2009 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Julie Tsai, (unknown), Wei Qiu, Qiaozhu Su, Mark Naples, Khosrow Adeli	41
10	Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B–containing lipoproteins 2008 ·Hepatology ·Wei Qiu, Lisa Federico, Mark Naples, Rita Kohen Avramoglu, Reza Meshkani, (unknown), Julie Tsai, M. Mahmood Hussain, Kezhi Dai, Jahangir Iqbal, Christopher D. Kontos, Yasuo Horie, Akira Suzuki, Khosrow Adeli	39
11	147 Co-translational Misfolding and Endoplasmic Reticulum Accumulation of Apolipoprotein B Induces Hepatic Insulin Resistance 2007 ·Cytokine ·Qiaozhu Su, Julie Tsai, Khosrow Adeli	2
12	Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins 2006 ·Journal of Lipid Research ·Wei Qiu, Rita Kohen Avramoglu, Angela C. Rutledge, Julie Tsai, Khosrow Adeli	39
13	MEK–ERK Inhibition Corrects the Defect in VLDL Assembly in HepG2 Cells 2006 ·Arteriosclerosis Thrombosis and Vascular Biology ·Julie Tsai, Wei Qiu, (unknown), Khosrow Adeli	64
14	PQN and DQN: Algorithms for expression microarrays 2006 ·Journal of Theoretical Biology ·Weimin Liu, Rui Li, (unknown), Jing Wang, Julie Tsai, Wen Wei, Alexander Kohlmann, P. Mickey Williams	20
15	Inhibition by Copper(II) Binding of Hepatocyte Growth Factor (HGF) Interaction with Its Receptor Met and Blockade of HGF/Met Function 2004 ·Journal of Biological Chemistry ·(unknown), Julie Tsai, Zongchao Jia, Bruce E. Elliott	9
16	Glucosamine-Induced Endoplasmic Reticulum Stress Promotes ApoB100 Degradation 2004 ·Arteriosclerosis Thrombosis and Vascular Biology ·Wei Qiu, (unknown), (unknown), Julie Tsai, Richard C. Austin, Khosrow Adeli	64
17	Effect of ileal bypass on serum lipoproteins in essential hypercholesterolemia 1968 ·Journal of Atherosclerosis Research ·E.H. Strisower, (unknown), Alex V. Nichols, (unknown), Julie Tsai	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact